AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34425471 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 204
Study 32076564 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning and Coping programme (LC-programme)
Number of subjects: 825
Study 32076564 — intervention group
Group type: COMPARATOR
Intervention: Standard CR-programme
Number of subjects: 825
Study 34103386 — intervention group
Group type: EXPERIMENTAL
Intervention: Rucaparib 600 mg twice daily
Number of subjects: 151
Study 33021871 — intervention group
Group type: EXPERIMENTAL
Intervention: Afatinib plus Cetuximab
Number of subjects: 168
Study 33021871 — intervention group
Group type: COMPARATOR
Intervention: Afatinib alone
Number of subjects: 168
Study 36065653 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge training and telephone counseling for two months
Number of subjects: 70
Study 36065653 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 70
Study 34544599 — intervention group
Group type: EXPERIMENTAL
Intervention: Px563L (10 mcg)
Number of subjects: 54
Study 34544599 — intervention group
Group type: EXPERIMENTAL
Intervention: Px563L (50 mcg)
Number of subjects: 54
Study 34544599 — intervention group
Group type: EXPERIMENTAL
Intervention: Px563L (80 mcg)
Number of subjects: 54
Study 34544599 — intervention group
Group type: EXPERIMENTAL
Intervention: RPA563 (mrPA only)
Number of subjects: 54
Study 34544599 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 54
Study 34544599 — intervention group
Group type: EXPERIMENTAL
Intervention: Px563L (all doses)
Number of subjects: 54
Study 35696185 — intervention group
Group type: EXPERIMENTAL
Intervention: Semorinemab 1500 mg
Number of subjects: 422
Study 35696185 — intervention group
Group type: EXPERIMENTAL
Intervention: Semorinemab 4500 mg
Number of subjects: 422
Study 35696185 — intervention group
Group type: EXPERIMENTAL
Intervention: Semorinemab 8100 mg
Number of subjects: 422
Study 35696185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study 34274173 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial crural cut and overlay (MCC)
Number of subjects: 54
Study 34274173 — intervention group
Group type: COMPARATOR
Intervention: Lateral crural cut and overlay (LCC)
Number of subjects: 54
Study 36096842 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactofem plus letrozole
Number of subjects: 40
Study 36096842 — intervention group
Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 40
Study 32589339 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-enhanced group-based fitness intervention (eight in-person group sessions with mobile app and FitBit followed by 4 weeks of app and FitBit only)
Number of subjects: 49
Study 32589339 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 49
Study 35387621 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted group (RA, 37 patients)
Number of subjects: 81
Study 35387621 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy-assisted group (FA, 44 patients)
Number of subjects: 81
Study 35387621 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted group (RA)
Number of subjects: 81
Study 35387621 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy-assisted group (FA)
Number of subjects: 81
Study 34401684 — intervention group
Group type: EXPERIMENTAL
Intervention: ADIE (Aligning Dimensions of Interoceptive Experience)
Number of subjects: 121
Study 34401684 — intervention group
Group type: COMPARATOR
Intervention: Exteroceptive control therapy (emotional prosody identification)
Number of subjects: 121
Study 32957364 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-sensitive moxibustion self-administration + original antihypertensive drugs
Number of subjects: 600
Study 32957364 — intervention group
Group type: COMPARATOR
Intervention: Original antihypertensive drugs without heat-sensitive moxibustion
Number of subjects: 600
Study 33155035 — intervention group
Group type: EXPERIMENTAL
Intervention: Regularization method for Mendelian randomization analysis
Number of subjects: 0
Study 33155035 — intervention group
Group type: COMPARATOR
Intervention: Standard multivariable Mendelian randomization
Number of subjects: 0
Study 34172065 — intervention group
Group type: EXPERIMENTAL
Intervention: Coalition Check-Up
Number of subjects: 68
Study 34172065 — intervention group
Group type: COMPARATOR
Intervention: TA as usual
Number of subjects: 68
Study 32912142 — intervention group
Group type: EXPERIMENTAL
Intervention: Abscisic acid
Number of subjects: 56
Study 32912142 — intervention group
Group type: EXPERIMENTAL
Intervention: Gibberellin
Number of subjects: 56
Study 32912142 — intervention group
Group type: EXPERIMENTAL
Intervention: Drought
Number of subjects: 56
Study 32912142 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt
Number of subjects: 56
Study 35583232 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose clazakizumab (25 mg)
Number of subjects: 152
Study 35583232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 33529093 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated monovalent EV-71 vaccine
Number of subjects: 7325
Study 33529093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7325
Study 33093359 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 412
Study 33093359 — intervention group
Group type: COMPARATOR
Intervention: Non-aspirin
Number of subjects: 412
Study 35039189 — intervention group
Group type: EXPERIMENTAL
Intervention: modified constraint‐induced movement therapy (mCIMT)
Number of subjects: 32
Study 35039189 — intervention group
Group type: COMPARATOR
Intervention: bimanual training (BIT)
Number of subjects: 32
Study 33999159 — intervention group
Group type: EXPERIMENTAL
Intervention: CJR hospitals
Number of subjects: 1087177
Study 33999159 — intervention group
Group type: COMPARATOR
Intervention: Control hospitals
Number of subjects: 1087177
Study 32538495 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg/kg
Number of subjects: 100
Study 32703042 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional MMR vaccine
Number of subjects: 40
Study 32703042 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional Candida antigen
Number of subjects: 40
Study 32703042 — intervention group
Group type: COMPARATOR
Intervention: Intralesional saline
Number of subjects: 40
Study 32352811 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness practice (daily diary assessments)
Number of subjects: 25
Study 35419650 — intervention group
Group type: EXPERIMENTAL
Intervention: ELOM-080
Number of subjects: 47
Study 35419650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 34152785 — intervention group
Group type: EXPERIMENTAL
Intervention: Antigay condition
Number of subjects: 141
Study 34152785 — intervention group
Group type: COMPARATOR
Intervention: Progay condition
Number of subjects: 141
Study 32417819 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-tempo music
Number of subjects: 240
Study 32417819 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-tempo music
Number of subjects: 240
Study 32417819 — intervention group
Group type: EXPERIMENTAL
Intervention: Background music (both slow and fast tempo)
Number of subjects: 240
Study 32417819 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 240
Study 32417819 — intervention group
Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 240
Study 35533197 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamate infusion (0.125 M L-glutamic acid at 1.65 mL/kg/h)
Number of subjects: 303
Study 35533197 — intervention group
Group type: COMPARATOR
Intervention: Control (saline infusion)
Number of subjects: 303
Study 35533197 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamate infusion (in patients without diabetes)
Number of subjects: 303
Study 35533197 — intervention group
Group type: COMPARATOR
Intervention: Control (in patients without diabetes)
Number of subjects: 303
Study 35533197 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamate infusion
Number of subjects: 303
Study 34229698 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model for postoperative early-relapse
Number of subjects: 406
Study 34229698 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 406
Study 33993000 — intervention group
Group type: EXPERIMENTAL
Intervention: New type of 1D grating sample fabricated by combining laser‐focused atomic deposition and x‐ray interference lithography
Number of subjects: 0
Study 33115436 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker (ARB) treatment with irbesartan (150–300 mg)
Number of subjects: 81
Study 33115436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 33115436 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ARB and placebo
Number of subjects: 81
Study 33115436 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin treatment
Number of subjects: 81
Study 35395638 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow-derived mesenchymal stem cells (BM-MSCs)
Number of subjects: 27
Study 33413459 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg) in the morning
Number of subjects: 15
Study 33413459 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg) in the afternoon
Number of subjects: 15
Study 33413459 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 15
Study 36088445 — intervention group
Group type: EXPERIMENTAL
Intervention: PolyPrime intervention (online video and medication reviews scheduled twice)
Number of subjects: 120
Study 36088445 — intervention group
Group type: EXPERIMENTAL
Intervention: PolyPrime intervention
Number of subjects: 120
Study 32112507 — intervention group
Group type: EXPERIMENTAL
Intervention: dCBT
Number of subjects: 1711
Study 35394159 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 52
Study 35394159 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (alpha2-agonist)
Number of subjects: 52
Study 35394159 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine (alpha2-antagonist)
Number of subjects: 52
Study 35394159 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 52
Study 33844435 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-visiting program (Primeiros Laços)
Number of subjects: 80
Study 33844435 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 80
Study 36910402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral upper-extremity training
Number of subjects: 0
Study 36910402 — intervention group
Group type: COMPARATOR
Intervention: Upper limb exercise on the affected side only (Control)
Number of subjects: 0
Study 33441116 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate resistance training (O55)
Number of subjects: 38
Study 33441116 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load resistance training (O80)
Number of subjects: 38
Study 33441116 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate resistance training (Y55)
Number of subjects: 38
Study 33441116 — intervention group
Group type: COMPARATOR
Intervention: Control group (younger men, Y55)
Number of subjects: 38
Study 34131846 — intervention group
Group type: EXPERIMENTAL
Intervention: Need-based program for family caregivers
Number of subjects: 64
Study 34131846 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 64
Study 32599668 — intervention group
Group type: EXPERIMENTAL
Intervention: Jennings Disaster Nursing Management Model‐based and learning management system‐assisted six‐module training programme
Number of subjects: 235
Study 34665996 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimalist Footwear Group (MFG)
Number of subjects: 42
Study 34665996 — intervention group
Group type: COMPARATOR
Intervention: Conventional Footwear Group (CFG)
Number of subjects: 42
Study 34665996 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MFG and CFG)
Number of subjects: 42
Study 33608590 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Number of subjects: 171
Study 33194565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate tissue adhesive (n = 23)
Number of subjects: 50
Study 33194565 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular suture (n = 24)
Number of subjects: 50
Study 33194565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate tissue adhesive
Number of subjects: 50
Study 33194565 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular suture
Number of subjects: 50
Study 33194565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate tissue adhesive and Subcuticular suture
Number of subjects: 50
Study 36506418 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic empowerment only (EE only)
Number of subjects: 900
Study 36506418 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple family group-based family strengthening only (MFG-based FS only)
Number of subjects: 900
Study 36506418 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined economic empowerment and multiple family group-based family strengthening (EE + MFG-based FS)
Number of subjects: 900
Study 32097435 — intervention group
Group type: EXPERIMENTAL
Intervention: ADVAX DNA prime followed by MVA boost
Number of subjects: 0
Study 32097435 — intervention group
Group type: COMPARATOR
Intervention: MVA alone
Number of subjects: 0
Study 32097435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35410375 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine and Dexamethasone
Number of subjects: 410
Study 35410375 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Supportive Care)
Number of subjects: 410
Study 34158030 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped learning integrated into SBME training on NTS
Number of subjects: 102
Study 34158030 — intervention group
Group type: COMPARATOR
Intervention: Lecture-based learning (LBL) on NTS
Number of subjects: 102
Study 32838783 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-administered screening with a 6.9 cm card for assessing baby's foot size.
Number of subjects: 2022
Study 34743455 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesion removal + whole breast exploration and washing + micro-plastic surgery
Number of subjects: 97
Study 34743455 — intervention group
Group type: COMPARATOR
Intervention: Empirical breast lesion resection + fascia tissue flap plasty + nipple and areola correction
Number of subjects: 97
Study 33244575 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty related to diseases
Number of subjects: 195
Study 35098601 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness app and activity tracker (treatment group)
Number of subjects: 216
Study 35098601 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fitness app or activity tracker)
Number of subjects: 216
Study 34214661 — intervention group
Group type: EXPERIMENTAL
Intervention: Congested side unilateral nostril breathing (UNB)
Number of subjects: 0
Study 34214661 — intervention group
Group type: COMPARATOR
Intervention: Patent side unilateral nostril breathing (UNB)
Number of subjects: 0
Study 34214661 — intervention group
Group type: COMPARATOR
Intervention: Breathing through both nostrils
Number of subjects: 0
Study 34209273 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beer (AB) - 330 mL/day
Number of subjects: 37
Study 34209273 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-alcoholic beer (NAB) - 660 mL/day
Number of subjects: 37
Study 34209273 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 32233247 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand power device and SJX external granule
Number of subjects: 50
Study 32233247 — intervention group
Group type: COMPARATOR
Intervention: Loose training of metacarpophalangeal joints
Number of subjects: 50
Study 34337827 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed message
Number of subjects: 2169
Study 34337827 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed material
Number of subjects: 2169
Study 34337827 — intervention group
Group type: COMPARATOR
Intervention: Gain-framed material
Number of subjects: 2169
Study 32306694 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week Balint group intervention
Number of subjects: 78
Study 32306694 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 78
Study 35199938 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced audit and feedback
Number of subjects: 0
Study 35199938 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple imputation
Number of subjects: 0
Study 34115953 — intervention group
Group type: EXPERIMENTAL
Intervention: L-DGG (Er,Cr:YSGG-harvested DGG and root surface biomodified)
Number of subjects: 24
Study 34115953 — intervention group
Group type: EXPERIMENTAL
Intervention: B-DGG/LRB (B-DGG and Er,Cr:YSGG root surface biomodification)
Number of subjects: 24
Study 34115953 — intervention group
Group type: COMPARATOR
Intervention: B-DGG (blade-harvested DGG, control group)
Number of subjects: 24
Study 35489789 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral arterial disease screening of at-risk patients with oversampling of high-risk racial groups
Number of subjects: 0
Study 35489789 — intervention group
Group type: EXPERIMENTAL
Intervention: Introduction of an intervention to alter a social determinant of health
Number of subjects: 0
Study 35489789 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of an algorithm that requires criteria be met prior to an amputation
Number of subjects: 0
Study 32717273 — intervention group
Group type: EXPERIMENTAL
Intervention: High Velocity Resistance Exercise (HVRE)
Number of subjects: 14
Study 32717273 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Resistance Exercise (TRE)
Number of subjects: 14
Study 34529773 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive determinants (Trail Making Test A and B)
Number of subjects: 249
Study 34529773 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical determinants (gait speed, lower extremity power, 6-Minute Walk Test, Figure of 8 Walk Test, tandem stance, energy cost of walking, Late-Life Function and Disability Function Scale)
Number of subjects: 249
Study 34529773 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial determinants (Modified Gait Efficacy Scale)
Number of subjects: 249
Study 34529773 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial determinants (neighborhood socioeconomic status)
Number of subjects: 249
Study 34529773 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 249
Study 34529773 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower extremity power
Number of subjects: 249
Study 34529773 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait efficacy
Number of subjects: 249
Study 34529773 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy cost of walking
Number of subjects: 249
Study 32285978 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavor- and taste-themed advertisements
Number of subjects: 1063
Study 32285978 — intervention group
Group type: EXPERIMENTAL
Intervention: People- and product use-themed advertisements
Number of subjects: 1063
Study 32285978 — intervention group
Group type: EXPERIMENTAL
Intervention: General advertisements
Number of subjects: 1063
Study 32285978 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior advertisement exposure
Number of subjects: 1063
Study 32285978 — intervention group
Group type: COMPARATOR
Intervention: Control advertisements for bottled water
Number of subjects: 1063
Study 35848935 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) group intervention, 14 sessions of 2 hours each
Number of subjects: 171
Study 34214668 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteomic analysis of glaucoma aqueous humour
Number of subjects: 175
Study 34214668 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteomic analysis of PAACG, PCACG, and NVG
Number of subjects: 175
Study 34214668 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteomic analysis of NVG
Number of subjects: 175
Study 34214668 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteomic analysis of PAACG
Number of subjects: 175
Study 34214668 — intervention group
Group type: EXPERIMENTAL
Intervention: SERPIND1 role in glaucoma
Number of subjects: 175
Study 32871336 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 34
Study 32871336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 35903434 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical enhanced endoscopy
Number of subjects: 188
Study 35903434 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard endoscopy)
Number of subjects: 188
Study 33077119 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg ⋅ kg‐1)
Number of subjects: 8
Study 33077119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 35261292 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey drops for postoperative care for 2 weeks
Number of subjects: 50
Study 35261292 — intervention group
Group type: COMPARATOR
Intervention: Warm saline solution for postoperative care
Number of subjects: 50
Study 33533652 — intervention group
Group type: EXPERIMENTAL
Intervention: Likert items with normal instructions
Number of subjects: 1798
Study 33533652 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced choice items with normal instructions
Number of subjects: 1798
Study 33533652 — intervention group
Group type: EXPERIMENTAL
Intervention: Likert items with instructions to make a positive impression
Number of subjects: 1798
Study 33533652 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced choice items with instructions to make a positive impression
Number of subjects: 1798
Study 33533652 — intervention group
Group type: EXPERIMENTAL
Intervention: Statements with normal instructions
Number of subjects: 1798
Study 33533652 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjectives with normal instructions
Number of subjects: 1798
Study 33533652 — intervention group
Group type: EXPERIMENTAL
Intervention: Statements with instructions to make a positive impression
Number of subjects: 1798
Study 33533652 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjectives with instructions to make a positive impression
Number of subjects: 1798